AQR Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-35,578
Closed -$479K 2269
2018
Q4
$479K Sell
35,578
-29,498
-45% -$497K ﹤0.01% 1793
2018
Q3
$1.26M Buy
65,076
+36
+0.1% +$766 ﹤0.01% 1604
2018
Q2
$1.66M Sell
65,040
-34,340
-35% -$801K ﹤0.01% 1510
2018
Q1
$2M Buy
99,380
+25,679
+35% +$599K ﹤0.01% 1362
2017
Q4
$1.48M Buy
73,701
+47,810
+185% +$940K ﹤0.01% 1513
2017
Q3
$536K Buy
+25,891
New +$438K ﹤0.01% 1914
2017
Q2
Sell
-44,196
Closed -$705K 2253
2017
Q1
$705K Sell
44,196
-322
-0.7% -$4.64K ﹤0.01% 1780
2016
Q4
$561K Buy
44,518
+35,945
+419% +$669K ﹤0.01% 1895
2016
Q3
$240K Buy
8,573
+2,499
+41% +$83.9K ﹤0.01% 2122
2016
Q2
$213K Sell
6,074
-16,557
-73% -$520K ﹤0.01% 2097
2016
Q1
$620K Buy
22,631
+2,437
+12% +$71.8K ﹤0.01% 1757
2015
Q4
$691K Buy
+20,194
New +$630K ﹤0.01% 1732

Other funds holding DPLO

AQR Capital Management's DPLO Position: Q1 2019 in Review

AQR Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 35,578 shares — an estimated $479K sold.

AQR Capital Management first reported a position in DPLO in Q4 2015 and held it in 12 quarters. The position peaked at $2M in Q1 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • AQR Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • AQR Capital Management sold 35,578 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $479K.
  • AQR Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 12 quarters.
  • AQR Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $2M in Q1 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.